JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
Yelp
YELP
$983M
| $4.46M | ﹤0.01% |
106,244
+64,704
| +156% | +$2.88M |
2013 Q2
18 quarters
|
|
|
PRTK
2652
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.45M | ﹤0.01% |
248,377
+87,596
| +54% | +$1.83M |
2016 Q4
4 quarters
|
|
2653
MongoDB
MDB
$29.1B
| $4.44M | ﹤0.01% |
+149,700
| New | +$4.38M |
2017 Q4
0 quarters
|
|
|
TARO
2654
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $4.44M | ﹤0.01% |
42,413
+26,656
| +169% | +$2.93M |
2015 Q4
8 quarters
|
|
2655
Meritage Homes
MTH
$4.16B
| $4.44M | ﹤0.01% |
173,306
+93,330
| +117% | +$2.31M |
2015 Q4
8 quarters
|
|
|
QEP
2656
DELISTED
QEP RESOURCES, INC.
QEP
| $4.44M | ﹤0.01% |
463,567
-556,193
| -55% | -$5.04M |
2013 Q2
18 quarters
|
|
|
ERF
2657
DELISTED
Enerplus Corporation
ERF
| $4.41M | ﹤0.01% |
450,723
-13,325
| -3% | -$122K |
2015 Q3
9 quarters
|
|
2658
Old National Bancorp
ONB
$9.53B
| $4.41M | ﹤0.01% |
252,655
+127,918
| +103% | +$2.3M |
2013 Q2
18 quarters
|
|
2659
Urban Edge Properties
UE
$2.5B
| $4.41M | ﹤0.01% |
172,857
+135,397
| +361% | +$3.36M |
2015 Q3
9 quarters
|
|
2660
PUT
Southern Company
SO
$96.5B
| $4.39M | ﹤0.01% |
91,400
+89,900
| +5,993% | +$4.58M |
2017 Q3
1 quarter
|
|
2661
United Fire Group
UFCS
$1.41B
| $4.39M | ﹤0.01% |
96,260
+8,670
| +10% | +$405K |
2013 Q2
18 quarters
|
|
2662
CALL
Johnson Controls International
JCI
$94.9B
| $4.38M | ﹤0.01% |
115,000
| – | – |
2017 Q3
1 quarter
|
|
2663
Fresenius Medical Care
FMS
$11.8B
| $4.38M | ﹤0.01% |
83,313
-273
| -0.3% | -$13.6K |
2013 Q2
18 quarters
|
|
2664
CALL
TC Energy
TRP
$61.5B
| $4.38M | ﹤0.01% |
+90,000
| New | +$4.4M |
2017 Q4
0 quarters
|
|
2665
CALL
Advanced Micro Devices
AMD
$1.04T
| $4.37M | ﹤0.01% |
425,000
+300,000
| +240% | +$3.51M |
2017 Q1
3 quarters
|
|
|
MNK
2666
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.36M | ﹤0.01% |
193,288
-54,419
| -22% | -$1.46M |
2013 Q3
17 quarters
|
|
|
GNCMA
2667
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $4.35M | ﹤0.01% |
111,570
-1,817
| -2% | -$74.1K |
2015 Q1
11 quarters
|
|
2668
Oppenheimer Holdings
OPY
$1.3B
| $4.34M | ﹤0.01% |
162,121
+45,610
| +39% | +$1.07M |
2013 Q2
18 quarters
|
|
|
TVRD
2669
Tvardi Therapeutics
TVRD
$15.2M
| $4.34M | ﹤0.01% |
9,857
-140
| -1% | -$63.8K |
2014 Q1
15 quarters
|
|
2670
CALL
PNC Financial Services
PNC
$88.3B
| $4.33M | ﹤0.01% |
+30,000
| New | +$4.15M |
2017 Q4
0 quarters
|
|
|
SCU
2671
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $4.33M | ﹤0.01% |
173,165
+1,894
| +1% | +$59.4K |
2013 Q2
18 quarters
|
|
2672
PUT
RH
RH
$2.28B
| $4.31M | ﹤0.01% |
50,000
+27,500
| +122% | +$2.49M |
2017 Q3
1 quarter
|
|
|
CRCM
2673
DELISTED
CARE.COM, INC.
CRCM
| $4.3M | ﹤0.01% |
238,677
+146,529
| +159% | +$2.56M |
2017 Q3
1 quarter
|
|
|
CNR
2674
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $4.3M | ﹤0.01% |
222,752
+222,584
| +132,490% | +$3.74M |
2016 Q2
6 quarters
|
|
|
ACIA
2675
DELISTED
Acacia Communications Inc
ACIA
| $4.3M | ﹤0.01% |
118,671
-49,441
| -29% | -$2.02M |
2016 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.